Experiences with

Revlimid

MM, for those that don't know has my white blood cells overtaking my marrow, then eventually bone tissue, and the treatment involve wiping out the cells using Revlimid and Brotezomib. Also, Dexamethazone is used as part of the 4 month long induction therapy, with the goal to put my in remission.

Just wondering if this stream of events can be triggered by Revlimid.

She has received R-Chop (6 courses) with no benefit (refractory) and is now on Monjuvi + Revlimid (6 months, 2 pet scans (March and June). There has been modest improvement in that a number of smaller nodes have gone but 1 large node in her abdomen has increased in size and "heat".

She is now 4 cycles into her 2nd line of treatment, Revlimid 25mg pill (21 of 28 days) and Monjuvi infusions (now every 2 weeks). She is looking forward to a petscan in mid June to see if this course is effectively working.

Can anyone please share your experience with Monjuvi + Revlimid so that we can have an idea as to what to expect? Thanks in advance.

Just finally getting back under control with increased Revlimid & Imuran ( along with Rituxan infusions)

First, I have Myelodysplastic Syndrome and take Revlimid to treat it. Second, I developed Osteoporosis 5 years ago, as a result of the medication. My doctor put me on Boniva first and I hurt so badly, he stopped it after the first dose. He then put me on Prolia and I did well on it.

Has anyone taken Revlimid (lenalidomide) for anemia due to MPN? My oncologist has recommended this. The cost is approximately $15,000 to $17.000 USD per month (copay after insurance) in the US.

My wife is on Revlimid. When she asked her oncologist how long she would have to be on it, he said "Until it stops working." Sounds familiar. Maybe by the time that one is treatment-resistant there will be a drug to target treatment-emergent cell types?

Stopped all Dex, Revlimid and other treatments in 2016. Remission still holding, but residual myeloma still present in my blood. I see my oncologist at Johns Hopkins every 6 months for blood work, check ups, and a yearly bone marrow biopsy.

"It belongs to the family of drugs called antitumor antibiotics." [5] [6a] Lenalidomide "(trade name Revlimid) is a derivative of thalidomide approved in the United States in 2005.

Six months back I started a thread: "Non-PCa Prescription Drugs: Thalidomide / Lenalidomide (Revlimid)" https://healthunlocked.com/advanced-prostate-cancer/posts/137369286/non-pca-prescription-drugs-thalidomide-lenalidomide-revlimid 18 months earlier, I had posted the Mainsail trial results where the

In follicular lymphoma, one of the key updates is the RELEVANCE study that compared rituximab (Rituxan) and chemotherapy with rituximab and lenalidomide (Revlimid; R2). This study was a large, international trial.

Leibowitz used "thalidomide 50 mg one night, alternating with Revlimid 5 mg the next". 5mg is a low dose (available doses range from 2.5mg to 25mg). First, the negative news.

target https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288622/ 5) CAR-NK https://www.mdanderson.org/publications/oncolog/may-june-2017/chimeric-antigen-receptordirected-natural-killer-cells-for-b-cel.html 6) Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab , CC-122 is next generation Revlimid

The ORIGIN trial (NCT00910910), which was evaluating Revlimid treatment for a new use as an initial therapy for chronic lymphocytic leukemia (CLL) in patients 65 years and older, showed higher rates of death in patients treated with Revlimid compared to those treated with chlorambucil.' : [/i]https:/

I have fNHL, diagnosed 2009, w&w until 2013, then Bendamustine/Rituxan, Revlimid and then 2016, R-EPOCH. I am finishing my final treatment next week!! Excited to finally be done chemo!

Also tried Clinical trial of Revlimid in February 2016, but had to stop after a month because of an allergic reaction.

approved along with the introduction of processes to capture side effects after a drug's approval, dramatically reshaping the Clinical Trial process into what we have today. 2) Thalidomide has successfully been used to treat CLL and only a few years ago the derivative drug Lenalidomide (trade name Revlimid

I also cover other antibodies, new and old, IMIDS (immune modulating drugs) such as lenalidomide (Revlimid) vaccines, and more.